RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Ultrasound-Guided Percutaneous Ethanol Ablation for the Management of Recurrent Thyroid Cancer: Evaluation of Efficacy and Impact on Disease Course

        Santiago Tofé,Iñaki Argüelles,Guillermo Serra,Honorato García,Antonia Barcelo,Vicente Pereg 대한갑상선학회 2020 International Journal of Thyroidology Vol.13 No.2

        Background and Objectives: Neck recurrences of thyroid cancer are frequently detected in routine ultrasound (US)follow-up. Broad management of these lesions may include active surveillance, surgery or local percutaneoustechniques, but for the latter, little is known about impact on long-term follow-up and need of subsequentradioactive iodine (RAI) therapy. Materials and Methods: 42 patients underwent US-guided ethanol ablation (EA)over 71 thyroid bed or lymph node confirmed recurrences. All volume reduction >50%, absence of power Dopplersignal and fine needle aspiration (FNA) washout thyroglobulin (Tg) value <1 ng/mL should be present to considera complete ablation. Patients with TNM stage I-II, ≤2 lesions and/or baseline plasma TSH-suppressed Tg level <0.2ng/mL did not undergo post-EA RAI therapy. Post-EA plasma Tg values were compared to baseline in patientswith and without subsequent RAI therapy. Results: 62 lesions (87.32%) achieved a complete ablation after a meanfollow-up of 40.5 months (range, 12-73). Four treated lesions (5.63%) recurred (3/39 and 1/32 in patients withand without subsequent RAI therapy), and 7 patients (16.66%) developed new recurrences throughout follow-up(5/19 and 2/23 with and without RAI therapy). Both plasma TSH-suppressed and TSH-stimulated Tg levelsdescended after EA in both groups, and 17/38 (44.73%) patients achieved a TSH-suppressed Tg <0.2 ng/mL,with no differences between both groups of patients. All EA procedures were conducted safely without seriousor persistent side effects. Conclusion: Successful EA were achieved safely in 87.32% of patients with recurrentthyroid cancer, with a positive effect on systemic disease as reflected by plasma post-EA Tg levels. A subset ofpatients with TNM stage III, ≤2 lesions and/or low pre-EA plasma Tg levels may not need subsequent RAI therapyafter successful ablation. Overall, EA is an effective and balanced therapy for selected patients with neck recurrentthyroid cancer as an alternative to surgery.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼